| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA;
* Department of Biochemistry, Sapporo Medical University, Sapporo, Japan; and
Pathology Section, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
1Correspondence: Laboratory of Cell Biology, Building 37, Room 1B25, National Institutes of Health, Bethesda, MD 20892, USA. E-mail: hearingv{at}nih.gov
Various types of oculocutaneous albinism (OCA) are associated with reduced pigmentation in the skin, hair, and eyes that results from mutations in genes involved in melanin synthesis. Immortal mouse melanocyte lines (melan-a, melan-b, and melan-c) provide opportune models with which to investigate the etiology of two different types of OCA (types I and III), which arise from mutations in Tyr and Tyrp1, respectively. We compared intracellular processing, sorting, and degradation of tyrosinase and Tyrp1, and the effects on their catalytic function and melanin synthesis, in these wild-type and mutant melanocytes. A mutation in either Tyr or Tyrp1 increased the time of association of tyrosinase and Tyrp1 with calnexin and Bip, which in turn resulted in the retention of these mutant products in the ER. A mutation in either gene selectively enhanced the duration and efficiency of chaperone interactions (even with the wild-type protein in the mutant melanocytes) and markedly slowed their transport to melanosomes. These results show that OCA1 and OCA3 are (in some cases, at least) ER retention diseases wherein a mutation in one melanogenic protein affects the maturation and stability of the other in the melanogenic pathway.—Toyofuku, K., Wada, I., Valencia, J. C., Kushimoto, T., Ferrans, V. J., Hearing, V. J. Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins.
Key Words: albinism • chaperones • pigmentation • melanogenesis
This article has been cited by other articles:
|
|
 |
|
  T. Kobayashi and V. J. Hearing Direct interaction of tyrosinase with Tyrp1 to form heterodimeric complexes in vivo J. Cell Sci., December 15, 2007; 120(24): 4261 - 4268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.-E. Costin and V. J. Hearing Human skin pigmentation: melanocytes modulate skin color in response to stress FASEB J, April 1, 2007; 21(4): 976 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. I. Popescu, C. Paduraru, R. A. Dwek, and S. M. Petrescu Soluble Tyrosinase is an Endoplasmic Reticulum (ER)-associated Degradation Substrate Retained in the ER by Calreticulin and BiP/GRP78 and Not Calnexin J. Biol. Chem., April 8, 2005; 280(14): 13833 - 13840. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hoashi, H. Watabe, J. Muller, Y. Yamaguchi, W. D. Vieira, and V. J. Hearing MART-1 Is Required for the Function of the Melanosomal Matrix Protein PMEL17/GP100 and the Maturation of Melanosomes J. Biol. Chem., April 8, 2005; 280(14): 14006 - 14016. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wang, A. R. Prescott, B. A. Spruce, J. Sanderson, and G. Duncan Sigma Receptor Antagonists Inhibit Human Lens Cell Growth and Induce Pigmentation Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1403 - 1408. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lavado, C. Olivares, J. C. Garcia-Borron, and L. Montoliu Molecular Basis of the extreme dilution mottled Mouse Mutation: A COMBINATION OF CODING AND NONCODING GENOMIC ALTERATIONS* J. Biol. Chem., February 11, 2005; 280(6): 4817 - 4824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. T. Esapa, R.A. J. McIlhinney, and D. J. Blake Fukutin-related protein mutations that cause congenital muscular dystrophy result in ER-retention of the mutant protein in cultured cells Hum. Mol. Genet., January 15, 2005; 14(2): 295 - 305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Slominski, D. J. Tobin, S. Shibahara, and J. Wortsman Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation Physiol Rev, October 1, 2004; 84(4): 1155 - 1228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-i. Yasumoto, H. Watabe, J. C. Valencia, T. Kushimoto, T. Kobayashi, E. Appella, and V. J. Hearing Epitope Mapping of the Melanosomal Matrix Protein gp100 (PMEL17): RAPID PROCESSING IN THE ENDOPLASMIC RETICULUM AND GLYCOSYLATION IN THE EARLY GOLGI COMPARTMENT J. Biol. Chem., July 2, 2004; 279(27): 28330 - 28338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Guyonneau, F. Murisier, A. Rossier, A. Moulin, and F. Beermann Melanocytes and Pigmentation Are Affected in Dopachrome Tautomerase Knockout Mice Mol. Cell. Biol., April 15, 2004; 24(8): 3396 - 3403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ando, H. Watabe, J. C. Valencia, K.-i. Yasumoto, M. Furumura, Y. Funasaka, M. Oka, M. Ichihashi, and V. J. Hearing Fatty Acids Regulate Pigmentation via Proteasomal Degradation of Tyrosinase: A NEW ASPECT OF UBIQUITIN-PROTEASOME FUNCTION J. Biol. Chem., April 9, 2004; 279(15): 15427 - 15433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Watabe, J. C. Valencia, K.-i. Yasumoto, T. Kushimoto, H. Ando, J. Muller, W. D. Vieira, M. Mizoguchi, E. Appella, and V. J. Hearing Regulation of Tyrosinase Processing and Trafficking by Organellar pH and by Proteasome Activity J. Biol. Chem., February 27, 2004; 279(9): 7971 - 7981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.-E. Costin, J. C. Valencia, W. D. Vieira, M. L. Lamoreux, and V. J. Hearing Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4 J. Cell Sci., August 1, 2003; 116(15): 3203 - 3212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Olivares, F. Solano, and J. C. Garcia-Borron Conformation-dependent Post-translational Glycosylation of Tyrosinase. REQUIREMENT OF A SPECIFIC INTERACTION INVOLVING THE CuB METAL BINDING SITE J. Biol. Chem., April 25, 2003; 278(18): 15735 - 15743. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
